BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 15283871)

  • 1. A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732].
    Swancutt D; Hobbs R; Fitzmaurice D; Mant J; Murray E; Jowett S; Raftery J; Bryan S; Davies M; Lip G
    BMC Cardiovasc Disord; 2004 Jul; 4():12. PubMed ID: 15283871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.
    Rhys GC; Azhar MF; Foster A
    Qual Prim Care; 2013; 21(2):131-40. PubMed ID: 23735694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
    Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
    Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.
    Fitzmaurice DA; Hobbs FD; Jowett S; Mant J; Murray ET; Holder R; Raftery JP; Bryan S; Davies M; Lip GY; Allan TF
    BMJ; 2007 Aug; 335(7616):383. PubMed ID: 17673732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice.
    Morgan S; Mant D
    Br J Gen Pract; 2002 May; 52(478):373-4, 377-80. PubMed ID: 12014534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial Fibrillation Screen, Management, and Guideline-Recommended Therapy in the Rural Primary Care Setting: A Cross-Sectional Study and Cost-Effectiveness Analysis of eHealth Tools to Support All Stages of Screening.
    Orchard J; Li J; Freedman B; Webster R; Salkeld G; Hespe C; Gallagher R; Patel A; Kamel B; Neubeck L; Lowres N
    J Am Heart Assoc; 2020 Sep; 9(18):e017080. PubMed ID: 32865129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.
    Kaasenbrood F; Hollander M; de Bruijn SH; Dolmans CP; Tieleman RG; Hoes AW; Rutten FH
    Br J Gen Pract; 2020 Jun; 70(695):e427-e433. PubMed ID: 31988084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm.
    Hill NR; Sandler B; Mokgokong R; Lister S; Ward T; Boyce R; Farooqui U; Gordon J
    J Med Econ; 2020 Apr; 23(4):386-393. PubMed ID: 31855091
    [No Abstract]   [Full Text] [Related]  

  • 11. Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?
    Tarride JE; Quinn FR; Blackhouse G; Sandhu RK; Burke N; Gladstone DJ; Ivers NM; Dolovich L; Thornton A; Nakamya J; Ramasundarahettige C; Frydrych PA; Henein S; Ng K; Congdon V; Birtwhistle RV; Ward R; Healey JS
    Can J Cardiol; 2018 Nov; 34(11):1522-1525. PubMed ID: 30144961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for atrial fibrillation in general practice: a national, cross-sectional study of an innovative technology.
    Bury G; Swan D; Cullen W; Keane D; Tobin H; Egan M; Fitzmaurice D; Carberry C; Kelleher C
    Int J Cardiol; 2015 Jan; 178():247-52. PubMed ID: 25464263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England.
    Hill NR; Groves L; Dickerson C; Boyce R; Lawton S; Hurst M; Pollock KG; Sugrue DM; Lister S; Arden C; Davies DW; Martin AC; Sandler B; Gordon J; Farooqui U; Clifton D; Mallen C; Rogers J; Camm AJ; Cohen AT
    J Med Econ; 2022; 25(1):974-983. PubMed ID: 35834373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening strategies for atrial fibrillation].
    Terrier J; Carballo S
    Rev Med Suisse; 2015 Oct; 11(490):1892, 1894-6, 1898. PubMed ID: 26665658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study.
    Fitzmaurice DA; McCahon D; Baker J; Murray ET; Jowett S; Sandhar H; Holder RL; Hobbs FD
    Fam Pract; 2014 Jun; 31(3):298-302. PubMed ID: 24728774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland.
    Moran PS; Teljeur C; Harrington P; Smith SM; Smyth B; Harbison J; Normand C; Ryan M
    Value Health; 2016 Dec; 19(8):985-995. PubMed ID: 27987649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording.
    Aronsson M; Svennberg E; Rosenqvist M; Engdahl J; Al-Khalili F; Friberg L; Frykman-Kull V; Levin LÅ
    Europace; 2015 Jul; 17(7):1023-9. PubMed ID: 25868469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Fibrillation Screen, Management And Guideline Recommended Therapy (AF SMART II) in the rural primary care setting: an implementation study protocol.
    Orchard JJ; Neubeck L; Freedman B; Webster R; Patel A; Gallagher R; Li J; Hespe CM; Ferguson C; Zwar N; Lowres N
    BMJ Open; 2018 Oct; 8(10):e023130. PubMed ID: 30385444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study.
    Svennberg E; Engdahl J; Al-Khalili F; Friberg L; Frykman V; Rosenqvist M
    Circulation; 2015 Jun; 131(25):2176-84. PubMed ID: 25910800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study.
    Savickas V; Stewart AJ; Rees-Roberts M; Short V; Bhamra SK; Corlett SA; Mathie A; Veale EL
    PLoS Med; 2020 Jul; 17(7):e1003197. PubMed ID: 32678820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.